American scientists have proven the safety of the anti-aging drug Rapamycin: it delays cell aging and has minimal side effects, reports rsute.ru. The results of a long-term experiment - treatment with encapsulated rapamycin of monkeys, are published in the scientific journal "Aging".
Scientists have invented the anti-aging drug Rapamycin and conducted a scientific experiment on its use in monkeys. The results of treatment with Rapamycin were positive: minimal side effects, noted the Internet portal wordyou.ru. This drug was discovered by scientists in 2009: with its help, genetics wanted to extend the life of laboratory mice. Scientists at the University of Texas Health and Southwestern National Primate Research Center have decided to test Rapamycin on primates. “As it turns out, the anti-aging drug has worked well in monkeys as well,” said Associate Professor Corinna Ross, study leader.
"This study with monkeys as a scientific model of human aging allowed us for the first time to evaluate the effectiveness of a new interventional treatment - it has shown promise in other animal species, promoting health and increasing longevity."
Dr. Souzette Tardiff confirms what a colleague says about the effectiveness of Rapamycin in primates, as monkeys are a unique model for human drug development. Molecular biologist Adam Salmon of Barshop Research Institute emphasized: "Through experiments with Rapamycin in primates, we have taken a huge step towards translational approaches that postpone age-related diseases through pharmaceutical inhibition of mTOR (the mechanical goal of Rapamycin)."